Creo Medical (CREO) Price & Analysis

Compare

58 Followers

CREO Stock Chart & Stats

Day’s Range― - ―

52-Week Range9.22p - 37.00p

Previous CloseN/A

Volume60.81K

Average Volume (3M)449.16K

Market Cap

£50.53M

Enterprise Value121.04M

Total Cash (Recent Filing)£9.80M

Total Debt (Recent Filing)£14.20M

Price to Earnings (P/E)―

Beta0.49

Next Earnings

Sep 22, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding412,473,330

10 Day Avg. Volume821,099

30 Day Avg. Volume449,160

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

£12.50

Price Target Upside3.14% Upside

Rating ConsensusHold

Number of Analyst Covering1

Creo Medical News

Creo Medical to Announce Interim Results and Host Investor Presentation

An update from Creo Medical ( ($GB:CREO) ) is now available. Creo Medical Group plc announced it will...

8d ago

Creo Medical’s Speedboat® Technology Demonstrates Life-Changing Impact

Creo Medical ( ($GB:CREO) ) just unveiled an update. Creo Medical Group has highlighted the successful use of...

2M ago

Creo Medical Strengthens Share Incentive Plan with New Share Awards

The latest update is out from Creo Medical ( ($GB:CREO) ). Creo Medical Group PLC announced the acquisition...

2M ago

Creo Medical Reports Strong H1 2025 Growth and Strategic Advancements

Creo Medical ( ($GB:CREO) ) has issued an announcement. Creo Medical Group reported a 40% increase in core...

2M ago

Creo Medical Launches Landmark Study for Lung Tumor Treatment

Creo Medical ( ($GB:CREO) ) has provided an update. Creo Medical Group has initiated a landmark post-market clinical...

2M ago

Creo Medical Revises Executive Option Prices

Creo Medical ( ($GB:CREO) ) has shared an announcement. Creo Medical Group has announced a revision in the...

2M ago

Creo Medical Group Announces Change of Nominated Adviser to Deutsche Bank AG

Creo Medical ( ($GB:CREO) ) just unveiled an announcement. Creo Medical Group plc has announced a change in...

3M ago

Creo Medical Group Appoints Deutsche Bank as New Adviser

Creo Medical ( ($GB:CREO) ) has shared an announcement. Creo Medical Group plc has announced a change in...

3M ago

Creo Medical Group’s AGM Resolutions Passed Successfully

An announcement from Creo Medical ( ($GB:CREO) ) is now available. Creo Medical Group plc announced that all...

3M ago

Creo Medical Announces Strategic Progress and Board Changes at AGM

Creo Medical ( ($GB:CREO) ) has issued an announcement. Creo Medical Group, a leader in minimally invasive surgical...

3M ago

CREO FAQ

What was Creo Medical Group PLC’s price range in the past 12 months?

Creo Medical Group PLC lowest share price was 9.22p and its highest was 37.00p in the past 12 months.

What is Creo Medical Group PLC’s market cap?

Creo Medical Group PLC’s market cap is £50.53M.

When is Creo Medical Group PLC’s upcoming earnings report date?

Creo Medical Group PLC’s upcoming earnings report date is Sep 22, 2025 which is in 3 days.

How were Creo Medical Group PLC’s earnings last quarter?

Currently, no data Available

Is Creo Medical Group PLC overvalued?

According to Wall Street analysts Creo Medical Group PLC’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Creo Medical Group PLC pay dividends?

Creo Medical Group PLC does not currently pay dividends.

What is Creo Medical Group PLC’s EPS estimate?

Creo Medical Group PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Creo Medical Group PLC have?

Creo Medical Group PLC has 412,473,330 shares outstanding.

What happened to Creo Medical Group PLC’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Creo Medical Group PLC?

Currently, no hedge funds are holding shares in GB:CREO

Creo Medical Stock Smart Score

Underperform

Fundamentals

Return on Equity

-38.49%

Trailing 12-Months

Asset Growth

-21.87%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Creo Medical Group PLC

Creo Medical (CREO) is a pioneering medical device company focused on developing innovative technologies for minimally invasive surgical procedures. Operating in the healthcare sector, Creo specializes in advanced energy-based devices that utilize microwave and radiofrequency energy for the treatment of various conditions, primarily in gastroenterology and oncology. Their core products include the CROMA system, which is designed for targeted ablation of tumors and other tissue types, enhancing surgical precision and patient outcomes.

Creo Medical (CREO) Earnings & Revenues

Historic Earnings Reports

CREO Stock 12 Month Forecast

Average Price Target

12.50p

▲(3.14% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"11p","25":"25p","39":"39p","53":"53p","67":"67p"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">12.50p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">12.50p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">12.50p</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,25,39,53,67],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2022","6":"Mar<br/>2023","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.5,13.423076923076923,13.346153846153847,13.26923076923077,13.192307692307692,13.115384615384615,13.038461538461538,12.961538461538462,12.884615384615385,12.807692307692308,12.73076923076923,12.653846153846153,12.576923076923077,{"y":12.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.5,13.423076923076923,13.346153846153847,13.26923076923077,13.192307692307692,13.115384615384615,13.038461538461538,12.961538461538462,12.884615384615385,12.807692307692308,12.73076923076923,12.653846153846153,12.576923076923077,{"y":12.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.5,13.423076923076923,13.346153846153847,13.26923076923077,13.192307692307692,13.115384615384615,13.038461538461538,12.961538461538462,12.884615384615385,12.807692307692308,12.73076923076923,12.653846153846153,12.576923076923077,{"y":12.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":66.11,"date":1661990400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":52.11,"date":1664582400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":41.98,"date":1667260800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":36.19,"date":1669852800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.37,"date":1672531200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.06,"date":1675209600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.25,"date":1677628800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.25,"date":1677628800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.75,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.25,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.5,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.5,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >